AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IMMUTEP LTD

0.048

0.000

Volume:1.02M

Turnover:48.90K

Market Cap:70.74M

PE:-0.84

High:0.049

Open:0.049

Low:0.047

Close:0.048

52wk High:0.470

52wk Low:0.028

Shares:1.47B

Float Shares:1.23B

Volume Ratio:2.62

T/O Rate:0.08%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.057

EPS(LYR):-0.042

ROE:-77.31%

ROA:-40.89%

PB:1.15

PE(LYR):-1.14

Loading ...

Overview Company News Filings

Immutep Ltd - Enrolment Halted; Immutep to Wind Down Study and Follow up With Patients

THOMSON REUTERS

Tacti-004 Phase Iii Study in First Line Nsclc to Be Discontinued Following Futility Analysis

THOMSON REUTERS

Immutep Ltd - Anticipates Cash Runway Extended Beyond Q2 Cy2027 After Trial Discontinuation

THOMSON REUTERS

Immutep Cut to Market Perform From Market Outperform by Citizens

Immutep Cut to Neutral From Outperform by Baird

BUZZ-Immutep craters 93% to record low after ceasing Phase III study of lung cancer drug

Immutep Ltd : Jefferies Downgrades Rating to Hold From Buy, Cuts Price Target to a$0.04 From a$2.20

THOMSON REUTERS

The ides of March come for Immutep as lung cancer trial cancellation triggers plummet

The Market Herald

Why CAR Group, Immutep, Northern Star, and Syrah Resources shares are sinking today

BRIEF-Immutep Says TACTI-004 To Be Discontinued Following Futility Analysis

Immutep to Discontinue Lung Cancer Trial Over Results of Efficacy, Safety Data Review; Shares Hit All-Time Low

MT Newswires Live

BRIEF-Immutep Seeks Trading Halt Pending Tacti-004 Trial Futility Analysis Outcome

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/IMM.AU/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMM.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMM.AU\",,,,,undefined,":{"symbol":"IMM.AU","market":"AU","secType":"STK","nameCN":"IMMUTEP LTD","latestPrice":0.048,"timestamp":1788223393496,"preClose":0.048,"halted":0,"volume":1023568,"delay":0,"changeRate":0,"nameEN":"IMMUTEP LTD","floatShares":1228247159,"shares":1473721306,"eps":-0.057294,"marketStatus":"Trading","change":0,"latestTime":"09-01 10:43:23 AEST","open":0.049,"high":0.049,"low":0.047,"amount":48900,"amplitude":0.041667,"askPrice":0.048,"askSize":265648,"bidPrice":0.047,"bidSize":289914,"shortable":3,"etf":0,"ttmEps":-0.057294,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788242400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.048,"openAndCloseTimeList":[[1788220800000,1788242400000]],"volumeRatio":2.623882,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"IMM.AU","preClose":0.048,"auctionPrice":0.048,"auctionVolume":30230,"auctionTime":1788220756168,"referenceTime":1788172203092,"auction":1,"marketStatus":"盘前竞价","timestamp":1788220756168}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMM.AU\",,,,,undefined,":{"symbol":"IMM.AU","floatShares":1228247159,"roa":"-40.89%","roe":"-77.31%","lyrEps":-0.042199,"volumeRatio":2.623882,"shares":1473721306,"dividePrice":0,"high":0.049,"amplitude":0.041667,"preClose":0.048,"low":0.047,"week52Low":0.028,"pbRate":"1.15","psRate":"3.08","week52High":0.47,"institutionHeld":0,"latestPrice":0.048,"committee":0.043678,"eps":-0.057294,"divideRate":0,"volume":1023568,"delay":0,"ttmEps":-0.057294,"open":0.049,"prevYearClose":0.415,"prevWeekClose":0.05,"prevMonthClose":0.048,"prevQuarterClose":0.053,"fiveDayClose":0.054,"twentyDayClose":0.047,"sixtyDayClose":0.047,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMM.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-06-05","symbol":"IMM.AU","defaultRemindTime":1717545600000,"type":"split","dateTimestamp":1717509600000,"forFactor":948148,"toFactor":1000000,"ratio":0.9481480000000001}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMM.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMM.AU\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2619194130","title":"Immutep Ltd - Enrolment Halted; Immutep to Wind Down Study and Follow up With Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2619194130","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619194130?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:01","pubTimestamp":1773403262,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nFWN40104Y:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","IMM.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619165194","title":"Tacti-004 Phase Iii Study in First Line Nsclc to Be Discontinued Following Futility Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2619165194","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619165194?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:01","pubTimestamp":1773403262,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nFWN40104Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","IMM.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619019416","title":"Immutep Ltd - Anticipates Cash Runway Extended Beyond Q2 Cy2027 After Trial Discontinuation","url":"https://stock-news.laohu8.com/highlight/detail?id=2619019416","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619019416?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:01","pubTimestamp":1773403262,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nFWN40104Y:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMM.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619196966","title":"Immutep Cut to Market Perform From Market Outperform by Citizens","url":"https://stock-news.laohu8.com/highlight/detail?id=2619196966","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619196966?lang=en_us&edition=fundamental","pubTime":"2026-03-13 18:44","pubTimestamp":1773398640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IMMP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 13, 2026 06:44 ET (10:44 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","IMM.AU","BK4139","BK7508","IMMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619119502","title":"Immutep Cut to Neutral From Outperform by Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2619119502","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619119502?lang=en_us&edition=fundamental","pubTime":"2026-03-13 18:35","pubTimestamp":1773398100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IMMP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 13, 2026 06:35 ET (10:35 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","IMM.AU","BK7067","IMMP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619157404","title":"BUZZ-Immutep craters 93% to record low after ceasing Phase III study of lung cancer drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2619157404","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619157404?lang=en_us&edition=fundamental","pubTime":"2026-03-13 12:10","pubTimestamp":1773375043,"startTime":"0","endTime":"0","summary":"BUZZ-Immutep craters 93% to record low after ceasing Phase III study of lung cancer drugUpdates** Shares of Immutep IMM.AX drop as much as 92.9% to a lifetime low of A$0.028** Stock logs its largest intraday pct drop** IMM trading 88.1% lower at 4.7 Australian cents a share, as of 0400 GMT** Australian biotechnology firm says an independent data monitoring committee for its TACTI-004 Phase III study for treatment of non-small cell lung cancer has recommended discontinuation of trial** Says recommendation following a planned interim futility analysis** Adds enrolment in the study to be halted, co to implement an orderly wind-down of the study** More than 379.3 million shares change hands, over 142 times the 30-day average** Jefferies downgrades IMM to \"hold\" from \"buy\", cuts PT to 4 cents from A$2.20. ** Brokerage calls it a \"surprising outcome\", says its valuation was based on one product, the efficacy of which is now in question","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nL4N4010A6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"BUZZ-Immutep craters 93% to record low after ceasing Phase III study of lung cancer drug","news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMM.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619157888","title":"Immutep Ltd  : Jefferies Downgrades Rating to Hold From Buy, Cuts Price Target to a$0.04 From a$2.20","url":"https://stock-news.laohu8.com/highlight/detail?id=2619157888","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619157888?lang=en_us&edition=fundamental","pubTime":"2026-03-13 11:49","pubTimestamp":1773373775,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nFWN4001YS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","IMM.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619152346","title":"The ides of March come for Immutep as lung cancer trial cancellation triggers plummet","url":"https://stock-news.laohu8.com/highlight/detail?id=2619152346","media":"The Market Herald","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619152346?lang=en_us&edition=fundamental","pubTime":"2026-03-13 10:44","pubTimestamp":1773369840,"startTime":"0","endTime":"0","summary":"Immutep Ltd  has seen its share price slaughtered on Friday after it’s effectively ditched its lead candidate for the treatment of lung cancer, a move that spells doom for any biotech – the speculative trader’s speculative investment class of choice.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week.On Spotify, Apple, and more.Cue Immutep sinking -88% in one intraday session – in fact, out the gate – down to 4.6cps. The stock closed at 40cps on Thursday – bringing Immutep’s YTD performance down negative -88%; its market cap to $68M, and its average liquidity to a more respectable level.if $11M feels low, note the company has 1.5B shares on issue. Still, for biotechs, that isn’t necessarily unusual –it’s a long hard road out of hell and to TGA  approval.The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"markerherald_stock","url":"https://themarketonline.com.au/the-ides-of-march-come-for-immutep-as-lung-cancer-trial-cancellation-triggers-plummet-2026-03-13/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/the-ides-of-march-come-for-immutep-as-lung-cancer-trial-cancellation-triggers-plummet-2026-03-13/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7067","IMM.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619590156","title":"Why CAR Group, Immutep, Northern Star, and Syrah Resources shares are sinking today","url":"https://stock-news.laohu8.com/highlight/detail?id=2619590156","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619590156?lang=en_us&edition=fundamental","pubTime":"2026-03-13 10:29","pubTimestamp":1773368943,"startTime":"0","endTime":"0","summary":"TheS&P/ASX 200 Index(ASX: XJO) is on course to end the week with a modest gain. In afternoon trade, the benchmark index is up 0.1% to 8,638.3 points. Four ASX shares that have failed to follow the mar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/13/why-car-group-immutep-northern-star-and-syrah-resources-shares-are-sinking-today/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/13/why-car-group-immutep-northern-star-and-syrah-resources-shares-are-sinking-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["CAR","BK7506","BK7507","BK4230","BK7104","BK4022","BK7503","SYR.AU","AAM.AU","BK7067","BK7508","NST.AU","CAR.AU","AAM","BK7002","BK7095","XJO.AU","IMM.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619559159","title":"BRIEF-Immutep Says TACTI-004 To Be Discontinued Following Futility Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2619559159","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619559159?lang=en_us&edition=fundamental","pubTime":"2026-03-13 08:53","pubTimestamp":1773363229,"startTime":"0","endTime":"0","summary":"BRIEF-Immutep Says TACTI-004 To Be Discontinued Following Futility AnalysisMarch 13 (Reuters) - Immutep Ltd IMM.AX:TACTI-004 TO BE DISCONTINUED FOLLOWING FUTILITY ANALYSISFurther company coverage: IMM.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nFWN4001Y6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMM.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619715508","title":"Immutep to Discontinue Lung Cancer Trial Over Results of Efficacy, Safety Data Review; Shares Hit All-Time Low","url":"https://stock-news.laohu8.com/highlight/detail?id=2619715508","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619715508?lang=en_us&edition=fundamental","pubTime":"2026-03-13 07:44","pubTimestamp":1773359069,"startTime":"0","endTime":"0","summary":"Immutep  will discontinue its Tacti-004 phase 3 trial, following recommendation from the Independent Data Monitoring Committee, according to a Friday filing with the Australian bourse.The committee's recommendation comes after a review of the available safety and efficacy data, per the filing.The study was evaluating eftilagimod alfa in patients in first line non-small cell lung cancer, the filing said. In response to the committee's recommendation, the company will stop patient enrollment and wind down the study.Immutep shares tumbled past 92% in recent Friday trade and earlier hit an all-time low.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","IMM.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2617502777","title":"BRIEF-Immutep Seeks Trading Halt Pending Tacti-004 Trial Futility Analysis Outcome","url":"https://stock-news.laohu8.com/highlight/detail?id=2617502777","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617502777?lang=en_us&edition=fundamental","pubTime":"2026-03-06 14:36","pubTimestamp":1772779011,"startTime":"0","endTime":"0","summary":"BRIEF-Immutep Seeks Trading Halt Pending Tacti-004 Trial Futility Analysis OutcomeMarch 6 (Reuters) - Immutep Ltd IMM.AX:SEEKS TRADING HALT PENDING TACTI-004 TRIAL FUTILITY ANALYSIS OUTCOMEFurther company coverage: IMM.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nFWN3ZT1FZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMM.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":4,"totalSize":72,"code":"91000000","status":"200"}]}}